rs104894309
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003002.4(SDHD):c.33C>A(p.Cys11*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C11C) has been classified as Benign.
Frequency
Consequence
NM_003002.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDHD | ENST00000375549.8 | c.33C>A | p.Cys11* | stop_gained | Exon 1 of 4 | 1 | NM_003002.4 | ENSP00000364699.3 | ||
ENSG00000255292 | ENST00000532699.1 | n.33C>A | non_coding_transcript_exon_variant | Exon 1 of 6 | 3 | ENSP00000456434.1 | ||||
TIMM8B | ENST00000504148.3 | c.-217G>T | upstream_gene_variant | 1 | NM_012459.4 | ENSP00000422122.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Paragangliomas 1 Pathogenic:4
ACMG: PVS1, PM2_Supporting, PP4 -
- -
- -
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
Pheochromocytoma;C1847319:Carney-Stratakis syndrome;C1868633:Paragangliomas with sensorineural hearing loss;CN166604:Cowden syndrome 3 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Cys11*) in the SDHD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SDHD are known to be pathogenic (PMID: 19454582, 19802898). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with pheochromocytoma and/or paraganglioma (PMID: 12000816, 18826997, 29386252). It is commonly reported in individuals of Polish ancestry (PMID: 12000816, 18826997, 29386252). ClinVar contains an entry for this variant (Variation ID: 6915). For these reasons, this variant has been classified as Pathogenic. -
Pheochromocytoma Pathogenic:1
Criteria applied: PVS1, PS4_MOD, PM2_SUP -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.C11* pathogenic mutation (also known as c.33C>A), located in coding exon 1 of the SDHD gene, results from a C to A substitution at nucleotide position 33. This changes the amino acid from a cysteine to a stop codon within coding exon 1 (p.C11*). This mutation has been reported in multiple individuals diagnosed with pheochromocytoma(s) and/or extra-adrenal paraganglioma(s) (Neumann HP et al. N. Engl. J. Med. 2002 May;346(19):1459-66; Peczkowska M et al. J. Clin. Endocrinol. Metab. 2008 Dec;93(12):4818-25; Michaowska I et al. Neuroendocrinology. 2015 Mar;101:321-30; Michaowska I et al. Kardiochir Torakochirurgia Pol. 2016 Sep;13:276-282). Peczkowaka and colleagues analyzed numerous p.C11* carrier families ascertained through the European-American PGL-PCC registry. In this series, the penetrance of head and neck PGLs in mutation carriers was 100% by age 54 and haplotype analysis data supported p.C11* as a founder mutation of Polish origin (Peczkowska M et al. J. Clin. Endocrinol. Metab. 2008 Dec;93(12):4818-25). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at